A Novel c.125 T>G (p.Val42Gly) Mutation in The Human INS Gene Leads to Neonatal Diabetes Mellitus via a Decrease in Insulin Synthesis

Abstract

Background Neonatal diabetes mellitus is likely caused by monogenic mutations, several of which have been identified. INS mutations have a broad spectrum of clinical presentations, ranging from severe neonatal onset to mild adult onset, which suggests that the products of different mutant INS alleles behave differently and utilize distinct mechanisms to induce diabetes. In this study, a neonatal diabetes mellitus patient’s INS gene was sequenced, and functional experiments were conducted.

Methods The neonatal diabetes mellitus patient’s genomic DNA was extracted, and the patient’s KCNJ11, ABCC8, and INS genes were sequenced. A novel mutation was identified in INS, and the open reading frame of this human mutant INS gene was inserted into the pMSCV-PIG plasmid. The constructed pMSCV-PIG plasmid was combined with VSV-g and Gag-pol and transfected into 293T cells to package the lentivirus. To stably overexpress the mutant gene, INS-1 cells were infected with the virus. The levels of insulin in the cell culture medium and cytoplasm were determined by ELISA and immunocytochemistry, respectively.

Results A heterozygous mutation, c.125T>G (p. Val42Gly), was identified in a neonatal diabetes mellitus patient’s INS gene. The human mutant INS open reading frame was overexpressed in INS-1 cells, and the mutant insulin was undetectable in the cell culture medium and cytoplasm.

Conclusions The novel heterozygous activating mutation c.125 T>G (p.Val42Gly) impairs the synthesis of insulin by pancreatic beta cells, resulting in diabetes.

Key words

insulin mutation - neonatal diabetes mellitus - insulin synthesis

• References

• 1 Stoy J, Edghill EL, Flanagan SE. et al. Insulin gene mutations as a cause of permanent neonatal diabetes. Proc Natl Acad Sci U S A 2007; 104: 15040-15044
• 2 Polak M, Cave H. Neonatal diabetes mellitus: A disease linked to multiple mechanisms. Orphanet J Rare Dis 2007; 14: 1356-1365
• 3 Iafusco D, Stazi MA, Cotichini R. et al. Permanent diabetes mellitus in the first year of life. Diabetologia 2002; 45: 798-804
• 4 Edghill EL, Dix RJ, Flanagan SE. et al. HLA genotyping supports a nonautoimmune etiology in patients diagnosed with diabetes under the age of 6 months. Diabetes 2006; 55: 1895-1898
• 5 Glaser B. Insulin mutations in diabetes: The clinical spectrum. Diabetes 2008; 57: 799-800
• 6 Pearson ER, Flechtner I, Njolstad PR. et al. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 2006; 355: 467-477
• 7 Liu M, Haataja L, Wright J. et al. Mutant INS-gene induced diabetes of youth: Proinsulin cysteine residues impose dominant-negative inhibition on wild-type proinsulin transport. PLoS One 2010;
• 8 Piccini B, Artuso R, Lenzi L. et al. Clinical and molecular characterization of a novel INS mutation identified in patients with MODY phenotype. Eur J Med Genet 2016; 59: 590-595
• 9 Bonfanti R, Colombo C, Nocerino V. et al. Insulin gene mutations as cause of diabetes in children negative for five type 1 diabetes autoantibodies. Diabetes Care 2009; 32: 123-125
• 10 Edghill EL, Flanagan SE, Patch AM. et al. Insulin mutation screening in 1,044 patients with diabetes: Mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood. Diabetes 2008; 57: 1034-1042
• 11 Liu M, Sun J, Cui J. et al. INS-gene mutations: From genetics and beta cell biology to clinical disease. Mol Aspects Med 2015; 42: 3-18
• 12 Colombo C, Porzio O, Liu M. et al. Seven mutations in the human insulin gene linked to permanent neonatal/infancy-onset diabetes mellitus. J Clin Invest 2008; 118: 2148-2156
• 13 Gloyn AL, Pearson ER, Antcliff JF. et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 2004; 350: 1838-1849
• 14 De Franco E, Flanagan SE, Houghton JA. et al. The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: An international cohort study. Lancet 2015; 386: 957-963
• 15 Stoy J, Steiner DF, Park SY. et al. Clinical and molecular genetics of neonatal diabetes due to mutations in the insulin gene. Rev Endocr Metab Disord 2010; 11: 205-215
• 16 Alarcon C, Leahy JL, Schuppin GT. et al. Increased secretory demand rather than a defect in the proinsulin conversion mechanism causes hyperproinsulinemia in a glucose-infusion rat model of non-insulin-dependent diabetes mellitus. J Clin Invest 1995; 95: 1032-1039
• 17 Dodson G, Steiner D. The role of assembly in insulin's biosynthesis. Curr Opin Struct Biol 1998; 8: 189-194
• 18 Steiner K, Bell J, Patch D. Case of the season: Multiple small liver lesions: An important differential. Semin Roentgenol 2011; 46: 90-92
• 19 Wang J, Takeuchi T, Tanaka S. et al. A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse. J Clin Invest 1999; 103: 27-37
• 20 Yoshinaga T, Nakatome K, Nozaki J. et al. Proinsulin lacking the A7-B7 disulfide bond, Ins2Akita, tends to aggregate due to the exposed hydrophobic surface. Biol Chem 2005; 386: 1077-1085
• 21 Nozaki J, Kubota H, Yoshida H. et al. The endoplasmic reticulum stress response is stimulated through the continuous activation of transcription factors ATF6 and XBP1 in Ins2+/Akita pancreatic beta cells. Genes Cells. 2004; 9: 261-270
• 22 Yoshida H. ER stress and diseases. FEBS J 2007; 274: 630-658
• 23 Zuber C, Fan JY, Guhl B. et al. Misfolded proinsulin accumulates in expanded pre-Golgi intermediates and endoplasmic reticulum subdomains in pancreatic beta cells of Akita mice. FASEB J 2004; 18: 917-919
• 24 Oyadomari S, Koizumi A, Takeda K. et al. Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes. J Clin Invest 2002; 109: 525-532
• 25 Ivarsson SA, Lernmark A. Comment on: Edghill et al. (2008) Insulin mutation screening in 1,044 patients with diabetes: Mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood. Diabetes 2008; 57: 1034-1042